2021
AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity
Muniraj T, Day LW, Teigen LM, Ho EY, Sultan S, Davitkov P, Shah R, Murad MH. AGA Clinical Practice Guidelines on Intragastric Balloons in the Management of Obesity. Gastroenterology 2021, 160: 1799-1808. PMID: 33832655, DOI: 10.1053/j.gastro.2021.03.003.Peer-Reviewed Original Research
2017
Patient and Disease Characteristics Associated With the Presence of Diabetes Mellitus in Adults With Chronic Pancreatitis in the United States
Bellin MD, Whitcomb DC, Abberbock J, Sherman S, Sandhu BS, Gardner TB, Anderson MA, Lewis MD, Alkaade S, Singh VK, Baillie J, Banks PA, Conwell D, Cote GA, Guda NM, Muniraj T, Tang G, Brand RE, Gelrud A, Amann ST, Forsmark CE, Wilcox CM, Slivka A, Yadav D. Patient and Disease Characteristics Associated With the Presence of Diabetes Mellitus in Adults With Chronic Pancreatitis in the United States. The American Journal Of Gastroenterology 2017, 112: 1457. PMID: 28741615, PMCID: PMC6168293, DOI: 10.1038/ajg.2017.181.Peer-Reviewed Original ResearchConceptsDiabetes mellitusChronic pancreatitisRisk factorsPancreas surgeryFamily historyType 2 diabetes mellitusMultivariate logistic regression modelingDM risk factorsLarge multicenter cohortStrong risk factorCross-sectional assessmentLogistic regression modelingCommon complicationCP patientsPatient demographicsMulticenter cohortExocrine insufficiencyPancreatic calcificationSingle centerDisease characteristicsDM diagnosisMultivariable modelSingle etiologyHigher oddsPatients
2012
Diabetes and pancreatic cancer.
Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterology 2012, 58: 331-45. PMID: 23207610, PMCID: PMC3932318.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBody Mass IndexClinical Trials as TopicDiabetes Mellitus, Type 2Early Detection of CancerEvidence-Based MedicineGlobal HealthGlucose IntoleranceHumansHyperinsulinismHypoglycemic AgentsInsulin GlargineInsulin, Long-ActingMeta-Analysis as TopicMetforminObesityPancreatic NeoplasmsPrevalenceRisk AssessmentRisk FactorsConceptsType 2 diabetesNew-onset diabetesPancreatic cancerPancreatic cancer-associated diabetesAnti-diabetic medicationsDuration of diseasePancreatic cancer patientsYears of ageGlucose toleranceCancer patientsOnset diabetesHigh riskEpidemiological studiesDiabetesCancerAdditional markersModest increaseRiskInverse relationshipRecent studiesMedicationsPatientsDisease